Raymond James Increases WELL Health Technologies (TSE:WELL) Price Target to C$11.00

WELL Health Technologies (TSE:WELL) had its price target raised by Raymond James from C$10.00 to C$11.00 in a report published on Tuesday,BayStreet.CA reports.

A number of other equities analysts also recently issued reports on WELL. TD Securities raised their price objective on WELL Health Technologies from C$8.00 to C$8.50 in a research report on Tuesday. Scotiabank raised their price target on shares of WELL Health Technologies from C$6.00 to C$7.00 in a report on Monday. CIBC upped their price objective on shares of WELL Health Technologies from C$5.25 to C$7.00 in a research note on Friday, December 13th. Haywood Securities lifted their target price on shares of WELL Health Technologies from C$8.00 to C$10.00 in a research note on Friday, December 13th. Finally, Ventum Financial dropped their target price on shares of WELL Health Technologies from C$8.00 to C$7.00 and set a “buy” rating on the stock in a report on Tuesday, October 29th.

WELL Health Technologies Stock Up 0.3 %

Shares of TSE:WELL opened at C$7.02 on Tuesday. The firm has a market cap of C$1.75 billion, a P/E ratio of 12.32, a P/E/G ratio of -1.93 and a beta of 1.20. WELL Health Technologies has a 12-month low of C$3.41 and a 12-month high of C$7.19. The business has a fifty day simple moving average of C$5.35 and a 200 day simple moving average of C$4.78. The company has a quick ratio of 1.02, a current ratio of 1.25 and a debt-to-equity ratio of 41.57.

WELL Health Technologies Company Profile

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.